Search Within

Isabelle C Riviere

  1. "Center for Hematologic Malignancies"
  2. "Biostatistics Service"
  3. "Glenn Heller"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (2)
Groups
  1. Biostatistics Service (10)
  2. Center for Hematologic Malignancies (10)
  3. Department of Medicine (10)
  4. Epidemiology and Biostatistics (10)
  5. GSK Faculty (10)
  6. Hematologic Malignancies Research (10)

More Groups

People
  1. Glenn Heller (10)
  2. Michel Sadelain (10)
  3. Xiuyan Wang (4)
  4. Clare Taylor (3)
  5. Farid Boulad (3)
  6. James Young (3)

More People

Years
  1. 2019 (1)
  2. 2016 (1)
  3. 2014 (1)
  4. 2013 (1)
  5. 2011 (1)
  6. 2008 (1)

More Years

Publications
  1. Blood (3)
  2. Molecular Therapy (2)
  3. Nature Biotechnology (2)
  4. Clinical and Experimental Immunology (1)
  5. Journal of Immunology (1)
  6. Journal of Immunotherapy (1)
Publishers
  1. Nature Publishing Group (4)
  2. American Society of Hematology (3)
  3. British Society for Immunology (1)
  4. Lippincott Williams & Wilkins (1)
  5. The American Association of Immunologists, Inc (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections
    Journal Article

    Hasan, A. N.; Selvakumar, A.; Shabrova, E.; Liu, X. R.; Afridi, F.; Heller, G.; Riviere, I.; Sadelain, M.; Dupont, B.; O'Reilly, R. J.
    Clinical and Experimental Immunology (2016)

    Fulltext@MSK | Save
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safe G-CSF mobilization of thalassemia patient CD34+cells and effective globin gene transduction for therapeutic infusion
    Meeting Abstract

    Boulad, F.; Wang, X. Y.; Taylor, C.; Qu, J. R.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Molecular Therapy (2013)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
    Journal Article

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Nature Biotechnology (2008)

    Fulltext@MSK | Save
  • Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications
    Journal Article

    Yuan, J.; Kendle, R.; Ireland, J.; Heller, G.; Sadelain, M.; Young, J. W.; Riviere, I.
    Journal of Immunotherapy (2007)

    Fulltext@MSK | Save
  • Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner
    Journal Article

    Yuan, J.; Latouche, J. B.; Hodges, J.; Houghton, A. N.; Heller, G.; Sadelain, M.; Riviere, I.; Young, J. W.
    Journal of Immunology (2006)

    Fulltext@MSK | Save
  • Langerhans cells modified by gene transfer of full length CMV pp65 are more potent inducers of cytolytic T lymphocytes in a CD4-dependent manner than either CMV p495 gene-modified or p495 peptide-pulsed Langerhans cells
    Meeting Abstract

    Yuan, J.; Latouche, J. B.; Hodges, J.; Heller, G.; Riviere, I.; Sadelain, M.; Young, J. W.
    Molecular Therapy (2004)

    Fulltext@MSK | Save
  • Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
    Journal Article

    Koehne, G.; Doubrovin, M.; Doubrovina, E.; Zanzonico, P.; Gallardo, H. F.; Ivanova, A.; Balatoni, J.; Teruya-Feldstein, J.; Heller, G.; May, C.; more...
    Nature Biotechnology (2003)

    Fulltext@MSK | Save